Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis (TICE)

This study is currently recruiting participants.
Verified November 2011 by Institut Claudius Regaud
Sponsor:
Information provided by (Responsible Party):
Institut Claudius Regaud
ClinicalTrials.gov Identifier:
NCT00864318
First received: March 16, 2009
Last updated: November 23, 2011
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)